0001950047-23-001094.txt : 20230531 0001950047-23-001094.hdr.sgml : 20230531 20230531165631 ACCESSION NUMBER: 0001950047-23-001094 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230531 DATE AS OF CHANGE: 20230531 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 23981800 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: AFEYAN NOUBAR CENTRAL INDEX KEY: 0001222012 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O FLAGSHIP PIONEERING, INC. STREET 2: 55 CAMBRIDGE PARKWAY, SUITE 800E CITY: CAMBRIDGE STATE: MA ZIP: 02142 144 1 primary_doc.xml 144 0001222012 XXXXXXXX LIVE 0001682852 MODERNA INC 001-38753 200 Technology Square Cambridge MA 02139 6177146500 NOUBAR B AFEYAN Director COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

15000 1933350.00 381209341 05/31/2023 NASDAQ Common 06/11/2013 Private Placement Issuer N 8515 06/11/2013 N/A Common 06/21/2012 Private Placement Issuer N 6485 06/21/2012 N/A N 10b5-1 Sales Plan for NOUBAR B AFEYAN

200 Technology Square Cambridge MA 02139

Common 03/01/2023 10000 1390000.00 The securities to be sold were acquired through a private placement during the period of 6/21/2012 through 6/11/2013 05/31/2023 02/27/2023 /s/ Noubar B. Afeyan